Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

NCT00099268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

747

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Carbidopa/levodopa/entacapone
DRUG: Immediate release carbidopa/levodopa

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]